Malaria parasite’s survival linked to two proteins
UC Riverside-led research could lead to novel antimalarial therapeutic strategies
O my, here’s Omicron
UC Riverside experts share their thoughts on the new COVID-19 variant
What UC Riverside scientists have to say about vaccines, variants, and antibodies
Immunity generated by vaccination is better than immunity from an actual infection, says an expert
Experts weigh in on whether COVID-19 is here to stay
COVID-19 is far from beaten. Vaccines may not be the ultimate panacea to haul us out of the pandemic crisis. In the future, will outbreaks of SARS-CoV-2, the virus that causes COVID-19, arrive in waves every winter? Might COVID-19 never go away? Experts at the University of California, Riverside, weigh...
Too much hype, too soon?
The news arrived Monday that the world has been awaiting since spring: a vaccine has been developed that shows a high degree of efficacy in late-stage trials: 90%. That puts it in the company of effective vaccines such as for measles, and well beyond what the medical community hoped for...
New research shows how the malaria parasite grows and multiplies
Study co-led by UC Riverside scientist could help develop strategies to combat the disease
Genome structure of malaria parasites linked to virulence
UC Riverside-led research could help develop novel therapeutic strategies to combat malaria
Generous funding to malaria-parasite researcher promises new therapeutic strategies
UC Riverside’s Karine Le Roch is principal investigator on two NIH grants
Research offers new insights into malaria parasite
A team of researchers led by a University of California, Riverside, scientist has found that various stages of the development of human malaria parasites, including stages involved in malaria transmission, are linked to epigenetic features and how chromatin — the complex of DNA and proteins within the nucleus — is...